AngioDynamics, Inc. (ANGO) Stock
AngioDynamics stock price chart
ANGO stock quote & key statistics
AngioDynamics annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2026 | $320.2M | -$36.7M | -$0.30 |
| FY2025 | $292.5M | -$34.0M | -$0.15 |
| FY2024 | $303.9M | -$184.3M | -$0.39 |
| FY2023 | $338.8M | -$52.4M | -$0.06 |
| FY2022 | $316.2M | -$26.5M | $0.00 |
Fiscal year ending May 31. Source: company filings via EODHD.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of medical devices dedicated to enhancing patient care through innovative solutions. Established in 1988 and based in Latham, New York, the company specializes in designing, manufacturing, and distributing a wide range of medical, surgical, and diagnostic devices used globally.
Focused on addressing critical healthcare needs, AngioDynamics' product portfolio includes advanced technologies for the treatment of peripheral vascular disease, vascular access, oncology, and surgical interventions. Their offerings encompass cutting-edge solutions such as the NanoKnife and Solero microwave tissue ablation systems, pivotal in surgical ablation and cancer treatment.
The company is renowned for its comprehensive suite of medical tools, including angiographic catheters, guidewires, and specialized drainage systems. These devices are integral in procedures ranging from thrombus management and atherectomy to managing venous insufficiency and delivering therapeutic agents directly into the central venous system.
AngioDynamics serves a diverse customer base that includes interventional radiologists, cardiologists, vascular surgeons, oncologists, urologists, and critical care nurses. Leveraging direct sales and strategic distribution partnerships, the company ensures its products reach healthcare providers worldwide, reinforcing its commitment to advancing medical outcomes through innovation and quality.
AngioDynamics stock FAQ
What is the AngioDynamics stock ticker symbol?
AngioDynamics, Inc. trades on the NASDAQ under the ticker symbol ANGO.
What sector and industry is AngioDynamics in?
AngioDynamics, Inc. is classified in the Healthcare sector, Medical Instruments & Supplies industry.
How many employees does AngioDynamics have?
AngioDynamics, Inc. has about 632 full-time employees.
What were AngioDynamics's revenue and earnings last fiscal year?
AngioDynamics reported revenue of $320.2M and net income of -$36.7M in fiscal 2026, with earnings per share of -$0.30. Revenue grew 9.5% from the prior year.
Is AngioDynamics in the Russell 2000?
Yes. AngioDynamics, Inc. (ANGO) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did AngioDynamics go public?
AngioDynamics stock began trading on May 27, 2004.
Russell 2000 Medical Instruments & Supplies stocks
All Russell 2000 →- ATRCAtriCure
- AZTAAzenta
- BTSGBrightSpring Health Services
- CYTKCytokinetics
- EMBCEmbecta
- GKOSGlaukos
- ICUIICU Medical
- KMTSKestra Medical Technologies
- KRMDKORU Medical Systems
- KRYSKrystal Biotech
- LMATLeMaitre Vascular
- MMEDMiniMed
- MMSIMerit Medical Systems
- OSUROraSure Technologies
- PCVXVaxcyte
- PDEXPro-Dex
- PLSEPulse Biosciences
- SMTISanara MedTech
- STAASTAAR Surgical
- STXSStereotaxis
- TWSTTwist Bioscience
- UTMDUtah Medical Products
- WRBYWarby Parker
- XRAYDENTSPLY SIRONA